Brookfield India Real Estate Trust Fund Raise of ₹10,305 Cr

Brookfield India Real Estate Trust Q2 FY27 Results: Net Profit ₹240.1 Cr, Up 72.1% YoY

Brookfield India Real Estate Trust reported revenue from operations of ₹996.4 Cr (+48.3% YoY) and net profit of ₹240.1 Cr (+72.1% YoY) for Q2 FY27.

Key figure

Net profit ₹240.1 Cr · +72.1% YoY

Brookfield India Real Estate Trust Merger & Restructuring Worth ₹1,700 Cr

Brookfield India REIT approved the acquisition of a 50% stake in Parthos Properties (GBKC Asset) at an enterprise value of ₹ 1,700 Crore.

Value

₹1,700 Cr

Brookfield India Real Estate Trust Other Announcement

Brookfield India REIT filed its quarterly statement on the utilization of proceeds from its Institutional Placements, confirming no deviations for the quarter ended June 30, 2026.

Brookfield India Real Estate Trust Management Change

Brookfield India Real Estate Trust's manager, Brookprop Management Services, appointed Gautam Mehra as an Independent Director and Danny Poljak as a Non-Independent Director.

Brookfield India Real Estate Trust Q1 FY27 Results: Net Profit ₹221.3 Cr, Up 67.3% YoY

Brookfield India Real Estate Trust reported revenue from operations of ₹973.8 Cr (+51.5% YoY) and net profit of ₹221.3 Cr (+67.3% YoY) for Q1 FY27.

Key figure

Net profit ₹221.3 Cr · +67.3% YoY

Brookfield India Real Estate Trust Board Meeting Date

Brookfield India Real Estate Trust scheduled a board meeting for August 10, 2026, to consider quarterly financial results and unit holder distributions.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.